Cramer Rosenthal Mcglynn LLC trimmed its holdings in Aramark (NYSE:ARMK) by 1.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,209,390 shares of the company’s stock after selling 12,260 shares during the period. Cramer Rosenthal Mcglynn LLC owned 0.49% of Aramark worth $51,689,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in ARMK. Cerebellum GP LLC acquired a new position in Aramark during the fourth quarter valued at approximately $127,000. Advisor Group Inc. raised its position in Aramark by 85.7% during the third quarter. Advisor Group Inc. now owns 3,342 shares of the company’s stock valued at $136,000 after purchasing an additional 1,542 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its position in Aramark by 91.7% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 3,450 shares of the company’s stock valued at $147,000 after purchasing an additional 1,650 shares in the last quarter. SG Americas Securities LLC raised its position in Aramark by 54.9% during the fourth quarter. SG Americas Securities LLC now owns 3,954 shares of the company’s stock valued at $169,000 after purchasing an additional 1,401 shares in the last quarter. Finally, Highlander Capital Management LLC acquired a new position in Aramark during the third quarter valued at approximately $203,000. Institutional investors own 94.69% of the company’s stock.
Several research analysts have commented on the stock. Royal Bank of Canada restated a “buy” rating and set a $50.00 price objective on shares of Aramark in a research report on Wednesday, February 7th. Morgan Stanley boosted their price objective on shares of Aramark from $41.00 to $42.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 31st. Nomura lowered their price objective on shares of Aramark from $47.00 to $45.00 and set a “buy” rating for the company in a research report on Wednesday, November 15th. Credit Suisse Group restated an “outperform” rating and set a $50.00 price objective on shares of Aramark in a research report on Wednesday, January 24th. Finally, Barclays boosted their price objective on shares of Aramark from $45.00 to $47.00 and gave the company an “equal weight” rating in a research report on Saturday, December 30th. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Aramark has a consensus rating of “Buy” and an average price target of $47.43.
Aramark (NYSE:ARMK) last posted its earnings results on Tuesday, February 6th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.03. The firm had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.88 billion. Aramark had a net margin of 3.65% and a return on equity of 18.68%. The company’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.55 earnings per share. sell-side analysts expect that Aramark will post 1.99 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Thursday, March 1st. Shareholders of record on Wednesday, February 14th were paid a dividend of $0.105 per share. The ex-dividend date was Tuesday, February 13th. This represents a $0.42 dividend on an annualized basis and a dividend yield of 1.00%. Aramark’s payout ratio is presently 19.53%.
COPYRIGHT VIOLATION WARNING: “Cramer Rosenthal Mcglynn LLC Has $51.69 Million Stake in Aramark (ARMK)” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/13/cramer-rosenthal-mcglynn-llc-has-51-69-million-stake-in-aramark-armk.html.
Aramark is a global provider of food, facilities and uniform services to education, healthcare, business and industry, and sports, leisure and corrections clients. The Company operates through three segments: Food and Support Services North America (FSS North America), Food and Support Services International (FSS International), and Uniform and Career Apparel (Uniform).
Want to see what other hedge funds are holding ARMK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aramark (NYSE:ARMK).
Receive News & Ratings for Aramark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aramark and related companies with MarketBeat.com's FREE daily email newsletter.